Erratum to: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy

Since publication of our article [1], we have regrettably noticed an error. The molarities of 16, 48, 80 and 112 μg/mL solutions of dNSurR9-C84A of molecular weight 42 kDa were incorrectly given as 1, 3, 5, and 7 μM. The correct molarities which should be used throughout are 0.38, 1.1, 1.9, and 2.7 μM, respectively.

Affiliations

1. Department of Molecular Medicine & Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand

   • Chun Hei Antonio Cheung
   • , Xueying Sun
   • , Jagat R Kanwar
   • , Ji-Zhong Bai
   •  & Geoffrey W Krissansen

2. Alternate address: The Hepatosplenic Surgery Center/Department of General Surgery, the First Clinical Medical School of Harbin Medical University, China

   • Xueying Sun

3. Graduate Institute of Vaccine Technology, National Pingtung University of Science and Technology, Pingtung, Taiwan

   • LiTing Cheng

4. National Institute of Cancer Research, National Health Research Institutes, Tainan, 70456, Taiwan

   • Chun Hei Antonio Cheung

5. Laboratory of Immunology and Molecular Biomedical Research (LIMBR), Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology & Research Innovation (ITRI), Deakin University, Geelong, Technology Precinct (GTP), Pigdons Road, Victoria, 3217, Australia

   • Jagat R Kanwar

Corresponding author

Correspondence to Geoffrey W Krissansen.

The online version of the original article can be found at 10.1186/1475-2867-10-36

Reprints and Permissions